Innate Pharma S.A. (IPHA)

IPHA Revenue & Earnings

Innate Pharma S.A. (IPHA) reported revenue of $2.79M and net income of $-49,177,000 for FY 2025, with a net profit margin of -1764.5%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.